Molecular Assay to Detect Metastatic Head and Neck Squamous Cell Carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 1, 2004, Pages 21-27

  Becker, Marta T ^a   Shores, Carol G ^a,b   Yu, Kathy K ^a   Yarbrough, Wendell G ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 20; CYTOKERATIN 5; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA SEQUENCE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHOID TISSUE; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; KERATINS; LYMPHATIC METASTASIS; MOLECULAR PROBES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0345743537     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.1.21     Document Type: Article

References (32)

1. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405-409.
2. Tu GY. Upper neck (level II) dissection of NO neck supraglottic carcinoma. Laryngoscope. 1999;109:467-470.
3. Ambrosch P, Bricbeck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology. 1996;10:1221-1226.
4. Ferlito A, Partridge M, Brennan J, Hamakawa H. Lymph node micrometastases in head and neck cancer: a review. Acta Otolaryngol. 2001;121:660-665.
5. Hamakawa H, Takemura K, Sumida T, Kayahara H, Tanioka H, Sogawa K. Histological study on pN upgrading of oral cancer. Virchows Arch. 2000;437:116-121.
6. Moll R, Franke WW, Schiller DL. The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell. 1982;31:11-24.
7. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: a new histologic marker detected by monoclonal antibodies. Am J Pathol. 1992;140:427-447.
8. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol. 1982;95:580-588.
9. McDonald LA, Walker DM, Gibbins JR. Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5. Oral Oncol. 1998;34:276-283.
10. Lersch R, Stellmach V, Stocks C, Giudice G, Fuchs E. Isolation, sequence, and expression of a human keratin K5 gene: transcriptional regulation of keratins and insights into pairwise control. Mol Cell Biol. 1989;9:3685-3697.
11. Vellucci VF, Germino FJ, Reiss M. Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization. Gene. 1995;166:213-220.
12. Marley JJ, Robinson PA, Hume WJ. Expression on human cytokeratin 14 in normal, premalignant, and malignant oral tissue following isolation by plaque differential hybridization. Eur J Cancer B Oral Oncol. 1994;30B:305-311.
13. Kawamata H, Uchida D, Nakashiro K, et al. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. BrJ Cancer. 1999;80:448-452.
14. Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;114:535-543.
15. lzbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188-1194.
16. Cai J, Ikeguchi M, Maeta M, Kaibara N. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery. 2000;127:32-39.
17. Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer. 1999;85:1098-1103.
18. Sasaki M, Watanabe H, Jass JR, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol. 1997;32:758-764.
19. Weitz J, Kienle P, Magener A, et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res. 1999;5:1830-1836.
20. Komukai S, Nishimaki T, Watanabe H, Ajioka Y, Suzuki T, Hatakeyama K. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery. 2000;127:40-46.
21. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol. 1997;4:447-451.
22. Hamakawa H, Fukuzumi M, Bao Y, et al. Keratin mRNA for detecting micrometastasis in cervical lymph nodes of oral cancer. Cancer Lett. 2000;160:115-123.
23. Hoon DSB, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol. 1995;13:2109-2116.
24. Morton DL. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
25. Eckert RL, Rorke EA. The sequence of the human epidermal 58-kD (#5) type II keratin reveals an absence of 5' upstream sequence conservation between coexpressed epidermal keratins. DNA. 1988;7:337-345.
26. Staggers WR, Paterson AJ, Kudlow JE. Sequence of the functional human keratin K14 promoter. Gene. 1995;153:297-298.
27. Liggett WH Jr, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D. p16 and p16β are potent growth suppressors of head and neck squamous carcinoma cell in vitro. Cancer Res. 1996;56:4119-4123.
28. Gusterson BA, Ott R. Occult axillary lymph-node micrometastases in breast cancer. Lancet. 1990;336:434-435.
29. Woolgar JA. Pathology of the NO neck. Br J Oral Maxillofac Surg. 1999;37:205-209.
30. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-399.
31. Balm AJ, Hageman PC, van Doornewaard MH, Groeneveld EM, Ivanyi D. Cytokeratin 18 expression in squamous cell carcinoma of the head and neck. EurArch Otorhinolaryngol. 1996;253:227-233.
32. Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res. 2001;7:4041-4048.